The effect of plasmapheresis and deoxyspergualin or cyclophosphamide treatment on anti-porcine Gal-alpha (1,3)-Gal antibody titres in humans.
Gannedahl
G
G
Department of Transplantation Surgery, University Hospital, Uppsala, Sweden.
Tufveson
G
G
Sundberg
B
B
Groth
C G
CG
D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis / Q000097:blood*; D000917:Antibody Formation; D015478:Antigens, Heterophile / Q000276:immunology*; D002240:Carbohydrate Sequence; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004187:Disaccharides / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008969:Molecular Sequence Data; D010956:Plasmapheresis; D013552:Swine
D000910:Antibodies, Heterophile; D015478:Antigens, Heterophile; D004187:Disaccharides; D006146:Guanidines; D007166:Immunosuppressive Agents; C055075:galactosyl-(1-3)galactose; D003520:Cyclophosphamide; C037258:gusperimus